Circulating miRNA is a useful diagnostic biomarker for nonalcoholic steatohepatitis in nonalcoholic fatty liver disease

QR Code

Circulating miRNA is a useful diagnostic biomarker for nonalcoholic steatohepatitis in nonalcoholic fatty liver disease

Abstract Nonalcoholic steatohepatitis (NASH) is considered as a progressive form of nonalcoholic fatty liver disease (NAFLD). To distinguish NASH from nonalcoholic fatty liver (NAFL), we evaluated the diagnostic value of circulating miRNAs. Small RNA sequencing was performed on 12 NAFL patients and...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Tae Hyung Kim, Yoonseok Lee, Young-Sun Lee, Jeong-An Gim, Eunjung Ko, Sun Young Yim, Young Kul Jung, SeongHee Kang, Moon Young Kim, Hayeon Kim, Baek-hui Kim, Ji Hoon Kim, Yeon Seok Seo, Hyung Joon Yim, Jong Eun Yeon, Soon Ho Um, Kwan Soo Byun
Format:	article
Langue:	EN
Publié:	Nature Portfolio 2021
Sujets:	Medicine R Science Q
Accès en ligne:	https://doaj.org/article/57af42f491184a57a296eb4ffbc08ce0
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Evaluation of the severity of nonalcoholic fatty liver disease through analysis of serum exosomal miRNA expression.
par: Jeong-An Gim, et autres
Publié: (2021)

Growth differentiation factor 15 ameliorates nonalcoholic steatohepatitis and related metabolic disorders in mice
par: Kook Hwan Kim, et autres
Publié: (2018)

Association between Equol Production Status and Nonalcoholic Steatohepatitis
par: Takemi Akahane, et autres
Publié: (2021)

Exosomes derived from palmitic acid-treated hepatocytes induce fibrotic activation of hepatic stellate cells
par: Young-Sun Lee, et autres
Publié: (2017)

Required warfarin dose and time in therapeutic range in patients with diagnosed Nonalcoholic Fatty Liver Disease (NAFLD) or Nonalcoholic Steatohepatitis (NASH).
par: Xuerong Wen, et autres
Publié: (2021)

The development of nonalcoholic steatohepatitis is subjected to breeder dependent variation in guinea pigs
par: D. H. Ipsen, et autres
Publié: (2021)

Treatment of nonalcoholic steatohepatitis with vitamins E and C: a pilot study
par: Kawanaka M, et autres
Publié: (2013)

CD4 derived double negative T cells prevent the development and progression of nonalcoholic steatohepatitis
par: Guangyong Sun, et autres
Publié: (2021)

Endoscopic duodenal mucosal resurfacing for nonalcoholic steatohepatitis (NASH): a pilot study
par: Alia Hadefi, et autres
Publié: (2021)

Anti-inflammatory and anti-fibrotic effects of modafinil in nonalcoholic liver disease
par: Shinkyu Choi, et autres
Publié: (2021)

The incidence trends of liver cirrhosis caused by nonalcoholic steatohepatitis via the GBD study 2017
par: Mimi Zhai, et autres
Publié: (2021)

Rat model of nonalcoholic steatohepatitis created by methionine and choline deficiency: biochemical and histological analyses
par: Seki A, et autres
Publié: (2011)

Baseline homeostasis model assessment of insulin resistance associated with fibrosis progression in patients with nonalcoholic fatty liver disease without diabetes: A cohort study.
par: Dae-Jeong Koo, et autres
Publié: (2021)

β-Cryptoxanthin alleviates diet-induced nonalcoholic steatohepatitis by suppressing inflammatory gene expression in mice.
par: Masuko Kobori, et autres
Publié: (2014)

Body weight variability and the risk of cardiovascular outcomes in patients with nonalcoholic fatty liver disease
par: Mi Na Kim, et autres
Publié: (2021)

Abdominal subcutaneous fat thickness and homeostasis model assessment of insulin resistance as simple predictors of nonalcoholic steatohepatitis
par: Hegazy MA, et autres
Publié: (2019)

The sex steroid precursor dehydroepiandrosterone prevents nonalcoholic steatohepatitis by activating the AMPK pathway mediated by GPR30
par: Longlong Li, et autres
Publié: (2021)

Activated Natural Killer Cell Promotes Nonalcoholic Steatohepatitis Through Mediating JAK/STAT PathwaySummary
par: Feixue Wang, et autres
Publié: (2022)

Effects of duodenal–jejunal bypass surgery in ameliorating nonalcoholic steatohepatitis in diet-induced obese rats
par: Yu HH, et autres
Publié: (2019)

Evaluating the Therapeutic Potential of Cenicriviroc in the Treatment of Nonalcoholic Steatohepatitis with Fibrosis: A Brief Report on Emerging Data
par: Diaz Soto MP, et autres
Publié: (2020)

The mechanism of increased intestinal palmitic acid absorption and its impact on hepatic stellate cell activation in nonalcoholic steatohepatitis
par: Masakazu Hanayama, et autres
Publié: (2021)

T Cell Subsets and Natural Killer Cells in the Pathogenesis of Nonalcoholic Fatty Liver Disease
par: Yoseph Asmelash Gebru, et autres
Publié: (2021)

Prokinetic effects of diatrizoate meglumine (Gastrografin®) in a zebrafish for opioid-induced constipation model
par: Dongwoo Kim, et autres
Publié: (2021)

Effect of sitagliptin on hepatic histological activity and fibrosis of nonalcoholic steatohepatitis patients: a 1-year randomized control trial
par: Alam S, et autres
Publié: (2018)

Albuminuria Is Associated with Steatosis Burden in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease (Diabetes Metab J 2021;45:698-707)
par: Eugene Han, et autres
Publié: (2021)

Pleiotropic actions of IP6K1 mediate hepatic metabolic dysfunction to promote nonalcoholic fatty liver disease and steatohepatitis
par: Sandip Mukherjee, et autres
Publié: (2021)

Nonalcoholic fatty liver disease is associated with the development of obstructive sleep apnea
par: Goh Eun Chung, et autres
Publié: (2021)

Body weight gain rather than body weight variability associated with increased risk of nonalcoholic fatty liver disease
par: Eun Ju Cho, et autres
Publié: (2021)

Study of Cytochrome P450 2E1 and its allele Variants in Liver Injury of Nondiabetic, Nonalcoholic Steatohepatitis Obese Women
par: VARELA,NELSON M, et autres
Publié: (2008)

CX3CR1 differentiates F4/80low monocytes into pro-inflammatory F4/80high macrophages in the liver
par: Young-Sun Lee, et autres
Publié: (2018)

Roles of IκB kinases and TANK-binding kinase 1 in hepatic lipid metabolism and nonalcoholic fatty liver disease
par: Jin Young Huh, et autres
Publié: (2021)

A novel, multitargeted endogenous metabolic modulator composition impacts metabolism, inflammation, and fibrosis in nonalcoholic steatohepatitis-relevant primary human cell models
par: Nadine Daou, et autres
Publié: (2021)

Efficacy and safety of canagliflozin in type 2 diabetes mellitus patients with biopsy-proven nonalcoholic steatohepatitis classified as stage 1–3 fibrosis
par: Seko Y, et autres
Publié: (2018)

AdipoR1/AdipoR2 dual agonist recovers nonalcoholic steatohepatitis and related fibrosis via endoplasmic reticulum-mitochondria axis
par: Hongjiao Xu, et autres
Publié: (2020)

The PPAR α/γ Agonist Saroglitazar Improves Insulin Resistance and Steatohepatitis in a Diet Induced Animal Model of Nonalcoholic Fatty Liver Disease
par: Divya P. Kumar, et autres
Publié: (2020)

The Influence of Natural and Anthropogenic Forcing on Water and Energy Balance and on Photosynthesis
par: Jaeyoung Song, et autres
Publié: (2021)

Liver biopsy in the quantitative assessment of liver fibrosis in nonalcoholic fatty liver disease
par: Gwyneth Shook Ting Soon, et autres
Publié: (2021)

A systematic review and meta-analysis of regional risk factors for critical outcomes of COVID-19 during early phase of the pandemic
par: Hyung-Jun Kim, et autres
Publié: (2021)

Anti-inflammatory and anti-osteoarthritis effect of Mollugo pentaphylla extract
par: Yun Mi Lee, et autres
Publié: (2019)

Changes in each retinal layer and ellipsoid zone recovery after full-thickness macular hole surgery
par: Min-Woo Lee, et autres
Publié: (2021)